Real Life Experience With Caduet [amlodipine/atorvastatin] Evaluating Effectiveness, Safety And Tolerability In The Management Of Cardiovascular Risk Factors (EXCEL Study)

Trial Profile

Real Life Experience With Caduet [amlodipine/atorvastatin] Evaluating Effectiveness, Safety And Tolerability In The Management Of Cardiovascular Risk Factors (EXCEL Study)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 24 Jun 2009

At a glance

  • Drugs Amlodipine/atorvastatin (Primary)
  • Indications Dyslipidaemias; Hypertension
  • Focus Therapeutic Use
  • Acronyms EXCEL
  • Sponsors Pfizer
  • Most Recent Events

    • 24 Jun 2009 Actual initiation date changed from Jan 2008 to Dec 2007, patient number chnaged from 143 to 112 as reported by ClinicalTrials.gov.
    • 24 Jun 2009 Primary endpoint changed to systolic and diastolic blood pressure as reported by ClinicalTrials.gov.
    • 05 May 2008 Status changed from initiated to discontinued and actual patient numbers updated as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top